MJ

Madan Jagasia

Chief Executive Officer

Obsidian Therapeutics

Nashville, Tennessee


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Obsidian Therapeutics
Industry
research
Employees
120.0
Seniority
C suite
Annual Revenue
4300000.0
Total Funding
325000000.0
Latest Funding
Series C

Professional Summary

Madan Jagasia serves as Chief Executive Officer at Obsidian Therapeutics. Obsidian Therapeutics operates in the research sector with approximately 120.0 employees. The company is headquartered in Nashville, Tennessee. Obsidian Therapeutics generates annual revenue of 4300000.0. To date, Obsidian Therapeutics has raised 325000000.0 in total funding, with the most recent round being Series C.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 2 executives at Obsidian Therapeutics.
  • 1,282 executive contacts are available in Tennessee.
  • Our database includes 201,469 c suite-level executives.

Technologies

Outlook Google Cloud Hosting Nginx Bootstrap Framework WordPress.org Mobile Friendly Typekit Google Tag Manager Google Font API Remote

Keywords

biotechnology research engineered therapeutics tumor infiltrating lymphocyte til therapy cytodrive platform membrane-bound il15 il2-free therapy advanced melanoma non-small cell lung cancer cell & gene therapy precision medicine drug responsive domains regulatory t cells small molecule regulation personalized treatments fda designation clinical trials autologous t cell therapy monoclonal antibodies immune checkpoint inhibitors antitumor activity synthetic biology therapeutic proteins immuno-oncology clinical efficacy safety profile pharmacologically regulated therapy biotechnology solid tumors patient-centric care cell-based therapies tumor microenvironment cancer therapy preclinical data biopharmaceuticals advanced therapy fast track designation expanded access policy innovative therapies collaborative research biotech pipeline patient outcomes immune-mediated oncology cytokine therapies therapeutic targets collaboration with pharma fda-approved drugs pipeline development engineered cell therapies gene therapies tumor-infiltrating lymphocyte (til) therapies obx-115 non-small cell lung cancer (nsclc) immunotherapy clinical-stage biotechnology regulated therapeutic proteins cancer treatment oncology patient-centric solutions transformative outcomes fda regenerative medicine advanced therapy designation collaborations pharmaceutical partnerships biotechnology industry advanced solid tumors therapeutic efficacy anti-tumor activity patient safety healthcare providers research institutions investment partnerships unmet medical needs health care health wellness & fitness hospital & health care

Related Executives

DA
Dana Alexander Chief Technical Officer at Obsidian Therapeutics
SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma

Frequently Asked Questions

How can I contact Madan Jagasia?

Madan Jagasia's verified email address is available on MessageCEO. They currently work at Obsidian Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Madan Jagasia lead?

Madan Jagasia is Chief Executive Officer at Obsidian Therapeutics, a company in the research sector with 120.0 employees. The company is based in Nashville, Tennessee.

What industry is Madan Jagasia in?

Madan Jagasia works in the research industry as Chief Executive Officer at Obsidian Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Madan Jagasia's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Madan Jagasia's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 22, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans